Revium Rx (RVRC) Assets (2024 - 2025)

Revium Rx's (RVRC) quarterly Assets came in at $8.3 million in Q4 2025, down 59.1% year-on-year from $20.3 million in Q4 2024, and down 59.1% quarter-over-quarter from $20.3 million in Q4 2024.

Revium Rx (RVRC) Assets (2024 - 2025) Analysis & Trends

Revium Rx has disclosed Assets across 2 years of filings, most recently posting $8.3 million for Q4 2025.

  • Assets for Q4 2025 came in at $8.3 million, down 59.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.3 million (down 59.1% YoY), and the FY2025 annual result was $8.3 million, down 59.1% from the prior year.
  • Assets came in at $8.3 million for Q4 2025 at Revium Rx, down from $20.3 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $20.3 million in Q4 2024 to a low of $8.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 9.13 Bn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 6.21 Bn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 3.31 Bn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 728.77 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 1.02 Bn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 1.12 Bn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 5.84 Bn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 1.42 Bn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 2.00 Bn
10 Revium Rx - - - 8.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.30 Mn
Dec 31, 2024 20.28 Mn